共 22 条
- [5] Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland[J] . Magdalena Leszczyszyn-Pynka,Bogusz Aksak-W?s,Anna Urbańska,Mi?osz Parczewski.PLoS ONE . 2017 (6)
- [6] Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients[J] . Baniasadi Shadi,Shokouhi Shokoufeh Baradaran,Tabarsi Payam,Alehashem Maryam,Khalili Hossein,Fahimi Fanak,Nadji Seyed Alireza.Tanaffos . 2016 (1)
- [7] The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand[J] . Bushyakanist A,Puangpetch A,Sukasem C,Kiertiburanakul S.Pharmacogenomics and Personalized Medicine . 2015 (defa)
- [8] HLA B*5701 status, disease progression, and response to antiretroviral therapy[J] . Jose,M.S..AIDS (London, England) . 2013 (16)
- [10] Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus–positive patients from southern Alberta[J] . Noureddine Berka,John M. Gill,Abdelhamid Liacini,Tyler O’Bryan,Faisal M. Khan.Human Immunology . 2012 (2)